Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2000
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375854A1 Novel liposomal vector complexes and their use in gene therapy
12/14/2000CA2375617A1 Targeted angiogenesis
12/14/2000CA2375424A1 Novel polynucleotides and polypeptides encoded thereby
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058729A1 Smad binding elements and uses thereof
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/13/2000EP1058558A1 Live recombined vaccines injected with adjuvant
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0680334B1 Morphogen treatment of gastrointestinal ulcers
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/13/2000CN1276794A Triplex forming oligonucleotides and their use in anti-HBV
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/12/2000US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents
12/12/2000US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159948 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
12/12/2000US6159946 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159732 Nucleic acid encoding mammalian Ubr1
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159710 Method and compositions for stabilizing unstable gene transcripts
12/12/2000US6159700 Method of finding agonist and antagonist to human and rat GPR14
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159696 Isolated human BMP-4 promoter region
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159467 In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy
12/12/2000US6159464 Administering a polypeptide
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159016 Method and system for producing personal golf lesson video
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073502A2 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000WO2000073500A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
12/07/2000WO2000073487A1 Novel viral vectors having enhanced effectiveness with dramatically reduced virulence
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073480A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
12/07/2000WO2000073479A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
12/07/2000WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
12/07/2000WO2000073477A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000WO2000073471A1 Cationic lipids for gene transfer and preparation method thereof
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073463A1 Groel muteins with improved stability
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073452A2 Compositions and methods for the treatment of immune related diseases
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073448A1 Adipocyte complement related protein homolog zacrp7
12/07/2000WO2000073433A1 Screening method for peptides
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073340A1 C-cam as an angiogenesis inhibitor
12/07/2000WO2000073329A2 Uses of notch related genes
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000072886A1 Episomally replicating lentiviral vectors
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072742A2 Methods and materials for generating sh3 domains with tailored binding properties
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000063402A8 Cassette regulating the expression of a heterologous nucleic acid in a eucaryotic cell, especially a muscle cell
12/07/2000WO2000050568A3 Transplantation of haematopoietic cells
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000044410A3 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy
12/07/2000DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/07/2000CA2823479A1 Compositions for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2385822A1 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375325A1 Uses of notch related genes
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 870